First human test: new drug EB070 enters safety trial
NCT ID NCT07413536
Summary
This is a first-in-human study to check if a new injectable drug called EB070 is safe for people. Researchers will give single shots of EB070 at different dose levels to 36 healthy volunteers and closely monitor them for side effects. The main goal is to understand how the body handles the drug and to find a safe dose range for future testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.